Conference Description
The Radionuclide Theranostics for the Management of Cancer GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Together, academic and industry scientists, clinicians, and medical physicists will meet with the common goal of advancing the development and mechanistic understanding of radionuclide therapies. Held at a pivotal moment in the evolution of radionuclide-based precision medicine, this dynamic meeting features in-depth discussions, unpublished data, and provocative sessions that challenge current dogma. As the field experiences unprecedented growth, the program emphasizes innovation in target and biomarker discovery, the integration of emerging technologies, and strategies to optimize response. With interactive panels, poster sessions, and cross-sector collaboration, this conference offers a unique platform to shape the future of radiopharmaceutical therapy and drive impactful translational advances.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by March 14, 2026. Please check back for updates.
Globalization of Radioligand Therapy
Discussion Leaders
Speakers
Strategies for Target Selection
Discussion Leaders
Speakers
Biomarkers of Patient Selection and Outcomes
Discussion Leaders
Speakers
Radiopharmaceutical Therapy and the Tumor Microenvironment
Discussion Leaders
Speakers
Fact or Fiction: RPT as an Immune Activator
Discussion Leaders
Speakers
Balancing Potency and Protection: Molecular Strategies for Optimizing RPT Dosing
Discussion Leaders
Speakers
From Concept to Clinic Translation: Defining Success Across the Discovery and Development Pipeline
Discussion Leaders
Speakers
Clinical Implementation of RPTs: The Role of Dosimetry
Discussion Leaders
Speakers
Innovations in RPT: The Road Ahead
Discussion Leaders
Speakers
